Anthony Maida, Ph.D. has joined PharmaNet Development Group as vice president, Clinical Research. Dr. Maida will be responsible for leading PharmaNet’s oncology team. “Anthony’s experience spans the drug development process. He has a unique strength in his well balanced expertise across strategic, operational and financial aspects of the business,” said Dr. Robert Reekie, chief operating officer and senior executive vice president, Late Stage Development. “We are...